These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 39030559)
1. Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma. Wang X; Li X; Wei L; Yu Y; Hazaisihan Y; Tao L; Jia W J Ovarian Res; 2024 Jul; 17(1):150. PubMed ID: 39030559 [TBL] [Abstract][Full Text] [Related]
2. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related]
3. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database. Liu J; Xu W; Li S; Sun R; Cheng W Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439 [No Abstract] [Full Text] [Related]
4. Identification of STEAP3-based molecular subtype and risk model in ovarian cancer. Zhao Z; Sun C; Hou J; Yu P; Wei Y; Bai R; Yang P J Ovarian Res; 2023 Jun; 16(1):126. PubMed ID: 37386521 [TBL] [Abstract][Full Text] [Related]
5. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer. Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L Front Immunol; 2022; 13():943389. PubMed ID: 36003381 [TBL] [Abstract][Full Text] [Related]
6. Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer. Evans ET; Page EF; Choi AS; Shonibare Z; Kahn AG; Arend RC; Mythreye K Cancer Med; 2024 Sep; 13(17):e7368. PubMed ID: 39248018 [TBL] [Abstract][Full Text] [Related]
7. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma. Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201 [TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients. Liu J; Wu H; Wang Q; Jin S; Hou S; Shen Z; Zhao L; Xu S; Pang D Cancer Control; 2024; 31():10732748241288118. PubMed ID: 39340434 [TBL] [Abstract][Full Text] [Related]
9. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
10. A novel immune-related prognostic signature in epithelial ovarian carcinoma. Su T; Zhang P; Zhao F; Zhang S Aging (Albany NY); 2021 Apr; 13(7):10289-10311. PubMed ID: 33819196 [TBL] [Abstract][Full Text] [Related]
11. CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features. Luo X; Mo J; Zhang M; Huang W; Bao Y; Zou R; Yao L; Yuan L World J Surg Oncol; 2024 Feb; 22(1):44. PubMed ID: 38317230 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive profiling of endocrine metabolism identifies a novel signature with robust predictive value in ovarian cancer. Yu D; Luo Y; Guo R; Ma F; Chang Y; Dang J J Gene Med; 2024 May; 26(5):e3686. PubMed ID: 38689382 [TBL] [Abstract][Full Text] [Related]
13. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer. Zhang L; Chen H; Ding B; Jiang W J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347 [TBL] [Abstract][Full Text] [Related]
14. Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer. Wang X; Li X; Wang X J Cell Mol Med; 2021 Apr; 25(8):4053-4061. PubMed ID: 33675171 [TBL] [Abstract][Full Text] [Related]
15. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma. Wang S; Bai H; Fei S; Miao B Biochem Genet; 2024 Jun; 62(3):2332-2351. PubMed ID: 37898914 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo. Zeng S; Liu S; Feng J; Gao J; Xue F Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer. Wang J; Zhao S; Wang F; Wang J; Zhang Y Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077 [TBL] [Abstract][Full Text] [Related]
18. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq. Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614 [TBL] [Abstract][Full Text] [Related]
19. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies. Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J Front Immunol; 2024; 15():1244392. PubMed ID: 38694506 [TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer]. Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477 [No Abstract] [Full Text] [Related] [Next] [New Search]